Skip to main content
Article thumbnail
Location of Repository

A feasibility study of acceptance and commitment therapy for emotional dysfunction following psychosis

By R.G. White, A. Gumley, J. McTaggart, L. Rattrie, D. McConville, S. Cleare and G. Mitchell

Abstract

The experience of psychosis can lead to depression, anxiety and fear. Acceptance and Commitment Therapy (ACT) facilitates individuals to accept difficult mental experiences and behave in ways that are consistent with personally held values. This study was a single (rater) blind pilot randomised controlled trial of ACT for emotional dysfunction following psychosis. Twenty-seven participants with psychosis were randomised to either: ten sessions of ACT plus treatment as usual (TAU) or TAU alone. The Hospital Anxiety and Depression Scale, Positive and Negative Syndrome Scale, Acceptance and Action Questionnaire, Kentucky Inventory of Mindfulness Skills and Working Alliance Inventory were used. Individuals were assessed at baseline and 3 months post-baseline. The individuals randomised to receive ACT found the intervention acceptable. A significantly greater proportion of the ACT group changed from being depressed at time of entry into the study to not being depressed at follow-up. The ACT group showed a significantly greater increase in mindfulness skills and reduction in negative symptoms. Results indicated that individuals randomised to ACT had significantly fewer crisis contacts over the study. Changes in mindfulness skills correlated positively with changes in depression. ACT appears to offer promise in reducing negative symptoms, depression and crisis contacts in psychosis

Topics: RC0321
Publisher: Elsevier
Year: 2011
OAI identifier: oai:eprints.gla.ac.uk:56329
Provided by: Enlighten

Suggested articles

Citations

  1. (2007).Treatment of comorbid depression and alcohol use disorders in an inpatient setting: Comparison of acceptance and commitment therapy versus treatment as usual.
  2. (1996). A study of the interrelationship between and comparative interrater reliability of the SAPS,
  3. (1999). Acceptance and Commitment Therapy: An experiential approach to behavior change,
  4. (2006). Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: Pilot results.
  5. (2010). Assessing psychological trauma and PTSD.
  6. (2004). Assessment of mindfulness by self-report:
  7. (2009). Classical Mindfulness: an introduction to its theory and practice for clinical application.
  8. (2000). Cognitive approach to depression and suicidal thinking in psychosis. I: Ontogeny of post-psychotic depression.
  9. (2008). Cognitive behaviour therapy for schizophrenia: effect sizes, clinical models, and methodological rigor.
  10. (2009). Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia,
  11. (1995). Depression and schizophrenia.
  12. (1990). Depressive symptoms in the course of schizophrenia.
  13. (2005). Discovering statistics using SPSS.
  14. (1986). Dysfunctional control by client verbal behavior: The context of reason giving.
  15. (2005). Get out of your mind and into your life: The new Acceptance and Commitment Therapy.
  16. (1989). Group cognitive and contextual therapies in treatment of depression.
  17. (2007). Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
  18. how to get started. The Evidence-Based Medicine Working Group.
  19. (1996). Inter-rater reliability and the PANSS. Poster presented at the CINP Congress,
  20. (1996). Manual for Beck Depression Inventory-II.
  21. (2009). Mindfulness groups for distressing voices and paranoia: A replication and randomized feasibility trial.
  22. (2002). Mindfulness-based Cognitive Therapy for Depression: A New Approach to Preventing Relapse.
  23. (2007). Mindfulness: An intervention for anxiety in schizophrenia.
  24. (2004). Negative beliefs about self and illness: a comparison of individuals with psychosis with or without comorbid social anxiety disorder. Australian and New Zealand
  25. (2001). Normative data for the HADS from a large non-clinical sample.
  26. (2009). Post-psychotic PTSD: Associations with fear of recurrence and intolerance of uncertainty.
  27. (1989). Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers.
  28. (2011). Preliminary psychometric properties of the Acceptance and Action Questionnaire – II: A revised measure of psychological flexibility and acceptance. Manuscript submitted for publication.
  29. (2010). Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders.
  30. (1988). Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenia.
  31. (2008). Responding mindfully to distressing psychosis: A grounded theory analysis.
  32. (1991). SCID-PANSS: two tier diagnostic system for psychotic disorders.
  33. (1985). Suicide among schizophrenics: A review.
  34. (2002). The aetiology of postpsychotic posttraumatic stress disorder following a psychotic episode.
  35. (1985). The diagnostic value in assessing mood congruence in delusions and hallucinations, and their relationship to the affective state
  36. (1997). The Impact of Event Scale -Revised. In
  37. (2009). The Matrix Life Manual. http://www.drkevinpolk.com/20312.html Pull,
  38. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia.
  39. (1989). The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.
  40. (1998). The prevalence of co-morbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder.
  41. (2002). The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial.
  42. (2002). The validity of the Hospital Anxiety and Depression Scale: An updated literature review.
  43. (2007). The Voices Acceptance and Action scale (VASS). Pilot data.
  44. (1995). The well-built clinical question: a key to evidence-based decisions.
  45. (1998). Two-year outcome in firstepisode schizophrenia: predictive value of symptoms for quality of life.
  46. (1993). Users' guides to the medical literature: I.
  47. (1994). Why do people worry? Personality and Individual Differences,
  48. (1992). World Health Organisation

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.